A Selective Orexin-1 Receptor Antagonist Attenuates Stress-Induced Hyperarousal without Hypnotic Effects-Reference-Cited by-同舟云学术

A Selective Orexin-1 Receptor Antagonist Attenuates Stress-Induced Hyperarousal without Hypnotic Effects

Published:2015-01-12 Issue:3 Volume:352 Page:590-601
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Bonaventure Pascal,Yun Sujin,Johnson Philip L.,Shekhar Anantha,Fitz Stephanie D.,Shireman Brock T.,Lebold Terry P.,Nepomuceno Diane,Lord Brian,Wennerholm Michelle,Shelton Jonathan,Carruthers Nicholas,Lovenberg Timothy,Dugovic Christine

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference44 articles.

1. Injection of L-allylglycine into the posterior hypothalamus in rats causes decreases in local gaba which correlate with increases in heart rate

2. Alvaro G, Amantini D, Castiglioni E, Di Fabio R and Pavone F (2010) inventors, Glaxo Group Limited UK, assignee. N-{[(1S,4S,6S)-3-(2-Pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives as orexin receptor antagonists and their preparation and use for the treatment of diseases. WO2010063662A1

3. Hypocretin/orexin in arousal and stress

4. Neural Circuitry of Stress-Induced Insomnia in Rats

5. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-B;Cellular and Molecular Life Sciences;2024-07-06

2. On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding;Medicine in Drug Discovery;2024-06

3. Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist;Bioorganic & Medicinal Chemistry Letters;2024-03

4. Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease;Annual Review of Pharmacology and Toxicology;2024-01-23

5. Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders;Medicinal Research Reviews;2023-04-10